DOCSLIB.ORG

Prevalence and Associated Factors of External Punctal Stenosis Among

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text

Load more

ORIGINAL ARTICLE Prevalence and associated factors of external punctal stenosis among elderly patients in Turkey Prevalência e fatores associados à estenose externa do ponto lacrimal em pacientes idosos na Turquia MahMut Oğuz ulusOy1, MEHMET ATAKAN2, sertaç argun Kıvanç3 ABSTRACT RESUMO Purpose: To estimate the prevalence of external punctal stenosis (EPS) in the Objetivo: Estimar a prevalência de estenose externa do ponto lacrimal (EEPL) na po- elderly population and investigate associated factors. pulação idosa e investigar os fatores associados. Methods: A total of 278 patients ≥65 years of age were evaluated for evidence Métodos: Foram avaliados 278 pacientes ≥65 anos com estenose externa do ponto of EPS from January to July 2016. Associated systemic, ocular, demographic, lacrimal de janeiro a julho de 2016. Todos os fatores sistêmicos, oculares, demográ- and lifestyle factors were investigated. Multiple logistic regression analyses ficos e de estilo de vida associados foram investigados. Foram utilizadas análises de were applied to evaluate the factors related to having EPS. P values <0.05 were regressão logística múltipla para avaliar os fatores relacionados a estenose externa do considered statistically significant. ponto lacrimal, valores de p<0,05 foram considerados estatisticamente significativos. Results: The prevalence of EPS in this study population was 63.3%, with a mean Resultados: A prevalência de estenose externa do ponto lacrimal foi de 63,3%, com age of 70.67 ± 7.85 (65-92 years). The ocular factor that was most commonly idade média de 70,67 ± 7,85 (65-92 anos). O fator ocular mais relacionado com related to EPS was chronic blepharitis (48.9%). EPS was also associated with estenose externa do ponto lacrimal foi blefarite crônica. (IC de 95%, 0,08-0,96, taking glaucoma medications (95% CI, 0.08-0.96, p=0.043), smoking history (95% p=0,043), história de tabagismo (IC 95%, 0,13-0,84, p=0,021), ectrópio (IC 95%, 0,004- CI, 0.13-0.84, p=0.021), ectropion (95% CI, 0.004-0.26, p=0.001), complaints of 0,26, p=0,001), queixa de lacrimejamento (95% IC, 1,11-3,52, p=0,02) e atividade tearing (95% CI, 1.11-3.52, p=0.02), and outdoor occupational activity (95% CI, ocupacional ao ar livre (IC 95%, 3,42-9,97, p<0,05). 3.42-9.97, p<0.05). Conclusão: A estenose externa do ponto lacrimal é um distúrbio mais comum em Conclusions: EPS is more common in elderly patients than in the general popu- pacientes idosos do que na população em geral. Atividade ocupacional ao ar livre, lation. Outdoor occupational activity, taking antiglaucomatous medications, medicação antiglaucomatosa, ectrópio e tabagismo foram significativamente associados ectropion, and smoking are significantly associated with EPS. In addition, com estenose externa do ponto lacrimal. A decisão sobre tratamento cirúrgico deve surgical treatment decisions should be made after complete evaluation and ser dada após a avaliação completas dos fatores associados em cada paciente. interviewing the patients. Keywords: Lacrimal apparatus; Lacrimal duct obstruction; Blepharitis; Dry eye Descritores: Aparelho lacrimal; Obstrução dos ductos lacrimais; Blefarite; Síndromes syndromes; Aged; Turkey/epidemiology do olho seco; Idoso; Turquia/epidemiologia INTRODUCTION patient population that visited our general ophthalmology clinic External punctal stenosis (EPS) is a common disorder of the from January to July 2016. The participants were questioned about punctum. Regardless of the cause of EPS, this condition, which basic demographic data, complaints of epiphora, systemic disease, can be congenital or acquired, can cause epiphora as a result of glaucoma therapy, smoking history (patients were categorized accor- blockage of the lacrimal passage. The acquired form can originate ding to their smoking habits into three groups as follows: (1) current from topical or systemic medication use, various infections, lid smokers (people who smoke any tobacco product occasionally), (2) malposition, or different forms of trauma and tumors(1-3). Changes nonsmokers, and (3) ex-smokers (people who had smoked regularly caused by aging are also a risk factor for EPS(4). The prevalence of in the past and had quit smoking at least 1 year before the study), and EPS increases with age, and has been reported to be between 17.3% occupational history (grouped as outdoor or indoor activity). and 54.3%(5,6). A slit-lamp biomicroscopy was used to evaluate the external Because of the lack of research in this field, we aimed to evaluate punctum. EPS was visually graded according to the criteria used by the prevalence of EPS and associated factors in elderly patients in Kashkouli et al.(7). All patients with EPS had a grade 1 (severe punctal Turkey. stenosis) or grade 2 (less severe punctal stenosis) punctal opening (Table 1). In addition, the presence of pterygium, eyelid malposi- tions (ectropion, entropium, trichiasis, and distichiasis), chronic da­­ METHODS cryocystitis, cataract, and age-related macular degeneration were This cross-sectional study was performed in Konya, Turkey. also documented. Chronic dacryocystitis was revealed by performing Patients who were older than 65 years were recruited from the nasolacrimal duct irrigation. A dilated biomicroscopic examination Submitted for publication: February 14, 2017 Funding: No specific financial support was available for this study. Accepted for publication: April 6, 2017 Disclosure of potential conflicts of interest: None of the authors have any potential conflict of 1 Department of Ophthalmology, School of Medicine, Konya Research Hospital, Başkent University, interest to disclose. Konya, Turkey. 2 Corresponding author: Mahmut Oğuz Ulusoy. Başkent Üniversitesi Tıp Fakültesi. Konya Uygulama ve Department of Ophthalmology, Aksaray State Hospital, Aksaray, Turkey. Araştırma Hastanesi - E-mail: [email protected] 3 Department of Ophthalmology, School of Medicine, Uludağ University, Bursa, Turkey. Approved by the following research ethics committee: Başkent University Institutional Review Board and Ethics Committee (#94603339-604.01.02/2131). 296 Arq Bras Oftalmol. 2017;80(5):296-9 http://dx.doi.org/10.5935/0004-2749.20170072 ULUSOY MO, ET AL . of the fundus with a +78 diopters lens was performed to detect hundred twelve (40.3%) patients had bilateral EPS. The presence of age-related macular degeneration. epiphora was consistent with the EPS ratio (p=0.004). No sex domi- Suspected dry eye was also evaluated with tear film breakup nance was observed for EPS (p=0.45). time (BUT), fluorescein and rose bengal staining, and Schirmer’s Chronic blepharitis was found in 45.5% (80/176) of the patients test. The BUT was also measured by touching the inferotemporal with EPS (95% CI, 0.58-1.72, p=0.13), and this was the most common bulbar conjunctiva with a fluorescein sodium strip wetted with a ocular factor associated with EPS. The associations between the preservative-free isotonic saline. Patients were asked to blink, and presence of EPS and other demographic, occupational, ocular, and the precorneal tear film was examined under blue light illumination systemic factors are presented in table 2. using a slit-lamp biomicroscope. The mean value of three measu- rements was recorded. The BUT was considered low when it was less than 10 seconds. The corneal surface was then examined for Table 2. Demographic, lifestyle, ocular, and systemic factors associa- fluorescein staining, and its presence or absence was recorded. The ted with external punctal stenosis cases were labeled as asymptomatic if they did not complain of EPS (+) EPS (-) OR epiphora and their tear meniscus height was less than 2 mm. The a patients were labeled as having dry eye if they had a BUT less than Age (years) 72.77 ± 7.8 67.03 ± 6.54 0.89 (3.93-7.54) 10 s and positive corneal staining with fluorescein. Schirmer’s test Sex was performed in both eyes. Five minutes after the instillation of Male 88 (65.2%) 047 (34.8%) 0.95 (0.56-1.63) one drop of oxybuprocaine hydrochloride 0.4%, the inferior fornix Female 88 (61.5%) 055 (38.5%) Reference was gently blotted, and a precalibrated standard filter strip was Complaints of tearing placed in the lower temporal fornix for 5 min. During this time, the participants were instructed to look slightly upward and blink Yes 121 (69.5%) 053 (30.5%) 1.97 (1.12-3.52) normally. After removing the strip, the length of the strip that was No 055 (52.9%) 049 (47.1%) Reference wet was measured. The test result was considered positive if this Dry eye measurement was ≤5 mm. Yes 017 (50.0%) 017 (50.0%) 0.72 (0.33-1.56) This study was approved by Baskent University Institutional Review Board and Ethics Committee (Project no: 94603339-604.01.02/2131) No 159 (65.2%) 085 (34.8%) Reference and supported by the Baskent University Research Fund. Informed Blepharitis consent was obtained from all participants. The study adhered to the Yes 080 (58.8%) 056 (41.2%) 1.00 (0.58-1.72) tenets of the Declaration of Helsinki. No 096 (67.6%) 046 (32.4%) Reference Pterygium STATISTICAL ANALYSIS Yes 006 (40.0%) 009 (60.0%) 0.37 (0.11-1.23) Statistical data were analyzed using SPSS version 21.0 (IBM Corp., Armonk, NY, USA). Values were expressed as the mean ± standard No 170 (64.6%) 093 (35.4%) Reference deviation. The chi-square test with 95% confidence intervals (CIs) and Ectropion Fisher’s exact test were used to assess the effects of sex, systemic Yes 033 (97.1%) 001 (2.90%) 0.03 (0.004-0.26) disease, topical or systemic medication, smoking, and occupational No 143 (58.6%) 101(41.4%) Reference activity. Multiple logistic regression analyses were used to evaluate Hypertension the independent factors related to having EPS. P values <0.05 were considered statistically significant. Yes 067 (59.8%) 045 (40.2%) 0.71 (0.41-1.24) No 109 (65.7%) 057 (34.3%) Reference RESULTS Diabetes mellitus Yes 043 (58.1%) 031 (41.9%) 0.57 (0.31-1.05) A total of 278 patients were recruited, with a mean age of 70.67 ± 7.85 (65-92 years).
Recommended publications
  • Differentiate Red Eye Disorders

    Differentiate Red Eye Disorders

    Introduction DIFFERENTIATE RED EYE DISORDERS • Needs immediate treatment • Needs treatment within a few days • Does not require treatment Introduction SUBJECTIVE EYE COMPLAINTS • Decreased vision • Pain • Redness Characterize the complaint through history and exam. Introduction TYPES OF RED EYE DISORDERS • Mechanical trauma • Chemical trauma • Inflammation/infection Introduction ETIOLOGIES OF RED EYE 1. Chemical injury 2. Angle-closure glaucoma 3. Ocular foreign body 4. Corneal abrasion 5. Uveitis 6. Conjunctivitis 7. Ocular surface disease 8. Subconjunctival hemorrhage Evaluation RED EYE: POSSIBLE CAUSES • Trauma • Chemicals • Infection • Allergy • Systemic conditions Evaluation RED EYE: CAUSE AND EFFECT Symptom Cause Itching Allergy Burning Lid disorders, dry eye Foreign body sensation Foreign body, corneal abrasion Localized lid tenderness Hordeolum, chalazion Evaluation RED EYE: CAUSE AND EFFECT (Continued) Symptom Cause Deep, intense pain Corneal abrasions, scleritis, iritis, acute glaucoma, sinusitis, etc. Photophobia Corneal abrasions, iritis, acute glaucoma Halo vision Corneal edema (acute glaucoma, uveitis) Evaluation Equipment needed to evaluate red eye Evaluation Refer red eye with vision loss to ophthalmologist for evaluation Evaluation RED EYE DISORDERS: AN ANATOMIC APPROACH • Face • Adnexa – Orbital area – Lids – Ocular movements • Globe – Conjunctiva, sclera – Anterior chamber (using slit lamp if possible) – Intraocular pressure Disorders of the Ocular Adnexa Disorders of the Ocular Adnexa Hordeolum Disorders of the Ocular
  • Eyelid and Orbital Infections

    Eyelid and Orbital Infections

    27 Eyelid and Orbital Infections Ayub Hakim Department of Ophthalmology, Western Galilee - Nahariya Medical Center, Nahariya, Israel 1. Introduction The major infections of the ocular adnexal and orbital tissues are preseptal cellulitis and orbital cellulitis. They occur more frequently in children than in adults. In Schramm's series of 303 cases of orbital cellulitis, 68% of the patients were younger than 9 years old and only 17% were older than 15 years old. Orbital cellulitis is less common, but more serious than preseptal. Both conditions happen more commonly in the winter months when the incidence of paranasal sinus infections is increased. There are specific causes for each of these types of cellulitis, and each may be associated with serious complications, including vision loss, intracranial infection and death. Studies of orbital cellulitis and its complication report mortality in 1- 2% and vision loss in 3-11%. In contrast, mortality and vision loss are extremely rare in preseptal cellulitis. 1.1 Definitions Preseptal and orbital cellulites are the most common causes of acute orbital inflammation. Preseptal cellulitis is an infection of the soft tissue of the eyelids and periocular region that is localized anterior to the orbital septum outside the bony orbit. Orbital cellulitis ( 3.5 per 100,00 ) is an infection of the soft tissues of the orbit that is localized posterior to the orbital septum and involves the fat and muscles contained within the bony orbit. Both types are normally distinguished clinically by anatomic location. 1.2 Pathophysiology The soft tissues of the eyelids, adnexa and orbit are sterile. Infection usually originates from adjacent non-sterile sites but may also expand hematogenously from distant infected sites when septicemia occurs.
  • The Simplified Trachoma Grading System, Amended Anthony W Solomon,A Amir B Kello,B Mathieu Bangert,A Sheila K West,C Hugh R Taylor,D Rabebe Tekeraoie & Allen Fosterf

    The Simplified Trachoma Grading System, Amended Anthony W Solomon,A Amir B Kello,B Mathieu Bangert,A Sheila K West,C Hugh R Taylor,D Rabebe Tekeraoie & Allen Fosterf

    PolicyPolicy & practice & practice The simplified trachoma grading system, amended Anthony W Solomon,a Amir B Kello,b Mathieu Bangert,a Sheila K West,c Hugh R Taylor,d Rabebe Tekeraoie & Allen Fosterf Abstract A simplified grading system for trachoma was published by the World Health Organization (WHO) in 1987. Intended for use by non-specialist personnel working at community level, the system includes five signs, each of which can be present or absent in any eye: (i) trachomatous trichiasis; (ii) corneal opacity; (iii) trachomatous inflammation—follicular; (iv) trachomatous inflammation—intense; and (v) trachomatous scarring. Though neither perfectly sensitive nor perfectly specific for trachoma, these signs have been essential tools for identifying populations that need interventions to eliminate trachoma as a public health problem. In 2018, at WHO’s 4th global scientific meeting on trachoma, the definition of one of the signs, trachomatous trichiasis, was amended to exclude trichiasis that affects only the lower eyelid. This paper presents the amended system, updates its presentation, offers notes on its use and identifies areas of ongoing debate. Introduction (ii) corneal opacity; (iii) trachomatous inflammation—fol- licular; (iv) trachomatous inflammation—intense; and (v) tra- Trachoma is the most important infectious cause of blindness.1 chomatous scarring.19 Trachomatous inflammation—follicular Repeated conjunctival infection2 with particular strains of and trachomatous inflammation—intense are signs of active Chlamydia trachomatis3–5
  • World Report on Vision Infographic

    World Report on Vision Infographic

    World report on vision The Facts Projected number of people estimated to have age related macular degeneration and glaucoma, 2020–2030. 243.4 million 195.6 million Everyone, if they live long enough, will experience at least one eye condition in their lifetime. Age related macular degeneration (any) Cataract surgery US$ 6.9 billion 95.4 million Refractive error 76 million US$ 7.4 billion Glaucoma 2020 2030 US$14.3 billion (is the investment) needed globally to treat existing Eye conditions are projected to unaddressed cases of refractive error and cataract. increase due to a variety of factors, including ageing population, lifestyle and NCDs. At least 2.2 billion people live with a vision impairment In at least 1 billion of these cases, vision impairment low- and middle- high-income regions could have been prevented income regions or has yet to be addressed Unaddressed distance vision impairment in many low- and middle- income regions is 4x higher than in high- income regions. Unaddressed refractive error (123.7 million) Cataract (65.2 million) Glaucoma (6.9 million) Corneal opacities (4.2 million) Diabetic Retinopathy (3 million) Trachoma (2 million) Unaddressed presbyopia (826 million) Eye conditions The problem Some eye conditions do not typically cause vision impairment, but others can. Common eye conditions that do not typically cause vision impairment Eyelid Conjunctivitis Dry eye Eyelid Conjunctivitis Dry eye Availability inflammation Accessibility Cyst or Stye Benign growth SubconjunctivalSubconjunctival in thethe eyeeye haemorrhagehaemorrhage Acceptability Common eye conditions that can cause vision impairment Eye care services are poorly integrated into health systems. The availability, accessibility and acceptability of eye Cataract Corneal opacity GlaucomaGlaucoma care services have an influence on eye conditions and vision impairment.
  • Santen CEO Small Meeting

    Santen CEO Small Meeting

    Santen CEO Small Meeting Santen Pharmaceutical Co., Ltd. December 3, 2020 Copyright© 2020 Santen All rights reserved. 0 People with Eye Problems will Increase Further Population growth Visually impaired or blind Aging world Lifestyle change 2.2bn Environmental change Source： WHO World report on vision Copyright© 2020 Santen All rights reserved. 1 Ophthalmic Disease Landscape Stage 1 Stage 2 Stage 3 Stage 4 Africa China/Southeast Asia Japan/Western ③Wellness Myopia/ Ptosis ②Treatment of diseases and conditions that do NOT lead to vision loss Dry eye ①Treatment of diseases and conditions Trachoma/ that can cause vision loss Cataract/ Infections AMD Glaucoma Copyright© 2020 Santen All rights reserved. 2 Ophthalmic Disease and Drugs Market Retinitis Glaucoma Myopia （aged 5～19） Pigmentosa China：20mil. China：120mil. Worldwide：1.9mil.*3 Number of Japan：5mil. Asia：54mil. Japan：18.7/100K.*4 Patients*1 Market size （by value*2) Atropine formulation is No fundamental treatment or Drugs commercialized in some effective drugs to control the Market countries. disease progression x12 DE-127 jCell +α （Licensed from jCyte） China Japan Regional and Business Growth Led by Ecosystem Development and New Modality *1: 2020/Decision Resources, LLC. All right reserved. Reproduction, distribution, transmission or publication is prohibited. Reprinted with permission. *2: Copyright © 2020 IQVIA. IQVIA MIDAS 2019.1Q-4Q; Santen analysis based on IQVIA data. Reprinted with permission. *3 Hamel C. Retinitis pigmentosa. Orphanet J Rare Dis. 2006;1:40. *4: Japanese Ophthalmological Society Copyright© 2020 Santen All rights reserved. 3 Santen Business Model Sustainable growth enabled by our specialized knowledge with external expertise and technology (1) Ophthalmology (2) Wellness (3) Inclusion Competitiveness as a specialized company Copyright© 2020 Santen All rights reserved.
  • Piloting the Treatment of Retinopathy in India Diabetic Retinopathy and Retinopathy of Prematurity

    Piloting the Treatment of Retinopathy in India Diabetic Retinopathy and Retinopathy of Prematurity

    Piloting the Treatment of Retinopathy in India Diabetic Retinopathy and Retinopathy of Prematurity Report of an Independent External Evaluation Amaltas Piloting the Treatment of Retinopathy in India Diabetic Retinopathy and Retinopathy of Prematurity Amaltas July 2019 Acknowledgements This report provides an independent, external evaluation of a large programme of work on retinopathy funded by the Queen Elizabeth Diamond Jubilee Trust Fund with additional funding from the Helmsley Trust Fund. We gratefully acknowledge the support from LSHTM and PHFI. Dr. GVS Murthy, Dr. Clare Gilbert, Dr. Rajan Shukla and Dr. Tripura Batchu extended every support to the evaluators. The wonderful images are the work of photographer Rajesh Pande. Work on the programme was helmed by the Indian Institute of Public Health, Hyderabad, a centre of the Public Health Foundation of India, and the London School of Hygiene and Tropical Medicine, United Kingdom. The programme itself was a collaborative effort of many government and non government organisations and partners in India. This report has been prepared by Amaltas Consulting Private Limited, India. Amaltas (www.amaltas.asia) is a Delhi based organization with a mission to work within the broad scope of development to provide high quality consulting and research in support of accelerating improvements in the lives of people. The report was written by Dr. Suneeta Singh and Shivanshi Kapoor, Amaltas with support from Dr. Deepak Gupta, Consultant. TABLE OF CONTENTS Acronyms List of Figures List of Tables Executive
  • Freedman Eyelid Abnormalities

    Freedman Eyelid Abnormalities

    1/16/2018 1 1/16/2018 Upper Lid Lower Lid Protractors Retractors: Levator m. 3rd nerve function Muller’s m. Cranial Nerve VII function Sympathetic Function Inferior Tarsal Muscle Things to Note Lid Apposition to Globe Position of Lid Margins MRD = 3‐5 mm Canthal Insertions Brow Positions 2 1/16/2018 Ptosis Usually age related levator dehiscence, but sometimes a sign of neurologic, mechanical orbital or inflammatory disease Blepharospasm Sign of External Irritation or Neurologic Disease 3 1/16/2018 First Consider Underlying Orbital Disease Orbital Cellulitis, Pseudotumor, Wegener’s Graves Ophthalmopathy, Orbital Varix Orbital Tumors that can mimic inflammatory process: Lacrimal Gland CA, Lymphoma, Lymphangioma, etc. Lacrimal Gland – Dacryoadenitis or tumor Sinus Mucocele Without Inflammatory Appearance, consider above but also… Allergic Eyelid Edema Hormonal Shifts Systemic Disorder – Cardiac, Renal, Hepatic, Thyroid with edema Cutaneous Lymphoma Graves Ophthalmopathy –can just have lid edema w/o inflammatory appearance Lymphedema after trauma, surgery to lids or orbit (e.g. lymphatics in lateral canthus) Traumatic Leak of CSF into upper eyelid (JAMA Oph 2014;312:1485) Blepharochalasis Not True Edema, but might mimic it: Dermatochalasis, Hidden Eyelid or Sub‐Conjunctival Mass, Prolapsed Orbital Fat When your concerned about: Orbital Cellulitis Orbital Pseudotumor Orbital Malignancy Vascular – e.g. CC fistula Proptosis Chemosis Poor Motility Poor Vision Pupil abnormality – e.g. RAPD Orbital Pseudotumor 4 1/16/2018 Good Vision Good Motility
  • Blepharitis and the Sjögren's Patient

    Blepharitis and the Sjögren's Patient

    Volume 28, Issue 10 November 2010 Blepharitis and the Sjögren’s Patient by Gary N. Foulks, MD, Arthur and Virginia Keeney,Professor of Ophthalmology, University of Louisville, Louisville, KY lepharitis, one of the most common problems seen by eye care specialists, may affect as many as 30 mil- The SSF Announces Blion Americans.1 Its prevalence increases with age, though eye care specialists are seeing it more in young- 2010 Research Grant Recipients – er patients. Most significantly, this condition appears to be more prevalent in Sjögren’s syndrome patients.2,3 If left untreated, blepharitis can impact a patient’s Donations Made the Difference! eye health, appearance, contact lens use, and quality by Katherine Hammitt, SSF Vice President of Research, and of life. Unchecked blepharitis can compromise results Cynthia Williamson, SSF Research Associate of cataract or LASIK surgery. e are experiencing a distressing dichotomy in research What is Blepharitis? with more scientific opportunities in Sjögren’s than ever Blepharitis involves inflammation of the eyelid.4 It Wbefore that are ripe for research, and yet, with tough economic times experienced in the U.S. and throughout can be caused by a variety of factors (e.g., age, allergy, the world, the future of medical and scientific research is immune system problems, hormone changes, bacteria, uncertain. The National Institutes of Health, the federal and dermatitis). agency and largest dispenser of research funds in the world, Symptoms can range from irritation and redness of reports that the percentage of research grant applications the eyelid margin to problems with reading, using a that are funded by the NIH has dropped from 40% to computer, or watching television.
  • Guidelines for Universal Eye Screening in Newborns Including RETINOPATHY of Prematurity

    Guidelines for Universal Eye Screening in Newborns Including RETINOPATHY of Prematurity

    GUIDELINES FOR UNIVERSAL EYE SCREENING IN NEWBORNS INCLUDING RETINOPATHY OF PREMATURITY RASHTRIYA BAL SWASthYA KARYAKRAM Ministry of Health & Family Welfare Government of India June 2017 MESSAGE The Ministry of Health & Family Welfare, Government of India, under the National Health Mission launched the Rashtriya Bal Swasthya Karyakram (RBSK), an innovative and ambitious initiative, which envisages Child Health Screening and Early Intervention Services. The main focus of the RBSK program is to improve the quality of life of our children from the time of birth till 18 years through timely screening and early management of 4 ‘D’s namely Defects at birth, Development delays including disability, childhood Deficiencies and Diseases. To provide a healthy start to our newborns, RBSK screening begins at birth at delivery points through comprehensive screening of all newborns for various defects including eye and vision related problems. Some of these problems are present at birth like congenital cataract and some may present later like Retinopathy of prematurity which is found especially in preterm children and if missed, can lead to complete blindness. Early Newborn Eye examination is an integral part of RBSK comprehensive screening which would prevent childhood blindness and reduce visual and scholastic disabilities among children. Universal newborn eye screening at delivery points and at SNCUs provides a unique opportunity to identify and manage significant eye diseases in babies who would otherwise appear healthy to their parents. I wish that State and UTs would benefit from the ‘Guidelines for Universal Eye Screening in Newborns including Retinopathy of Prematurity’ and in supporting our future generation by providing them with disease free eyes and good quality vision to help them in their overall growth including scholastic achievement.
  • Shift Work: a Risk Factor for Central Serous Chorioretinopathy

    Shift Work: a Risk Factor for Central Serous Chorioretinopathy

    Shift Work: A Risk Factor for Central Serous Chorioretinopathy ELODIE BOUSQUET, MYRIAM DHUNDASS, MATHIEU LEHMANN, PIERRE-RAPHAE¨L ROTHSCHILD, VIRGINIE BAYON, DAMIEN LEGER, CIARA BERGIN, ALI DIRANI, TALAL BEYDOUN, AND FRANCINE BEHAR-COHEN PURPOSE: To investigate if shift work or sleep distur- and focal serous detachments of the neurosensory retina bances are risk factors for central serous chorioretinop- and retinal pigment epithelium alterations. The role of athy (CSCR). choroid hyperpermeability in the pathogenesis of CSCR DESIGN: Prospective case-control study. has been well documented recently with multimodal imag- 2 METHODS: Forty patients with active CSCR and 40 ing modalities. In CSCR patients, a thick choroid has controls (age- and sex-matched) were prospectively been reported not only in the affected eye but also in the recruited from the Ophthalmology Department of Hoˆtel fellow eye, which is consistent with bilateral choroidal Dieu Hospital, Paris, between November 2013 and hyperpermeability.2,3 December 2014. All patients were asked to complete a To date, several risk factors for CSCR have been questionnaire addressing previously described risk factors identified,3 and the most consistent is corticosteroid and working hours, as well as the Insomnia Severity exposure from therapeutic administration or from endog- Index (ISI), a validated instrument for assessing sleep enous overproduction, as in Cushing syndrome.4–6 disturbances. Corticosteroids were recently shown to induce RESULTS: The mean age of the CSCR group was 44
  • A Study of Prevalence of Dry Eye in Relation to Trachoma

    A Study of Prevalence of Dry Eye in Relation to Trachoma

    Original Research Article DOI: 10.18231/2395-1451.2017.0084 A study of prevalence of dry eye in relation to trachoma Dipak B. Patel1,*, Jyotindra N. Brahmbhatta2, Hemal V. Jasani3, Aditya P. Desai4, Parin K. Mehta5 1Professor, 4,5Resident Doctor, SBKS Medical Institute & Research Centre, Vadodara, Gujarat, 2Professor, CU Shah Medical College, Surendranagar, Gujarat, 3Cataract & Refractive Surgery, Dept. Ophthalmology, Netradeep Eye Hospital, Rajkot, Gujarat *Corresponding Author: Email: [email protected] Abstract Introduction: Dry eye disease is a multifactorial disorder of the tear film due to tear deficiency or excessive tear evaporation, which causes damage to the ocular surface leading to tear film instability and is associated with visual disturbances and symptoms of ocular discomfort. The prevalence of dry eye ranging from 5 to 35% Worldwide, while in India it is 29.25% based on OSDI data. Trachoma is the leading cause of infectious blindness worldwide. Destructive nature of trachoma causes dry eye in its chronic course. Materials and Methods: Total 100 patients were included in the cross-sectional study in the duration of one-year duration from February 2010 to February 2011 at Dhiraj General Hospital. They were subjected to slit-lamp biomicroscopy, Schirmer’s test I and TBUT. Prevalence of trachoma in diagnosed cases of dry eye was also studied. Results: Prevalence of dry eye during 2010-11 was 17.77%. Amongst them, the prevalence of trachoma was 5%. Mean age of patients was 44.7±14.09 years. Discussion: Dry eye is leading cause of ocular discomfort in OPD patients. Prevalence of dry eye increases with age.
  • Loss of Vision and Hearing

    Loss of Vision and Hearing

    Chapter 50 Loss of Vision and Hearing Joseph Cook, Kevin D. Frick, Rob Baltussen, Serge Resnikoff, Andrew Smith, Jeffrey Mecaskey, and Peter Kilima Although the loss of vision and hearing has multiple causes, account uncorrected refractive errors, but this change has not and the burden of these diseases is complex, three major points yet been approved. emerge from the outset: The major causes of adult-onset blindness are cataract (47.8 percent), glaucoma (12.3 percent), macular degeneration • Impairments of the essential senses of vision and hearing (8.7 percent), diabetic retinopathy (4.8 percent), trachoma contribute to early demise and are important causes of mor- (3.6 percent), and onchocerciasis (0.8 percent). Uncorrected bidity for individuals who are blind or deaf. refractive errors are also a major cause of morbidity related to • Cost-effective interventions are available to address several vision, but this type of disability is not included in the global causes of these burdens now. burden of disease by definition. It has been estimated to be on • The number of cost-effectiveness analyses of interventions the order of 15 percent of the total blind population and could to preserve hearing or vision in developing countries is quite add 50 percent to the low-vision population. However, there limited. are no published data to do more than speculate. The major causes of childhood vision loss have marked Table 50.1 summarizes the conditions causing the sensory regional variations. They include vitamin A deficiency (xeroph- deficits, the proposed interventions and sites of delivery, and thalmia) and ophthalmia neonatorum in low-income coun- the cost and effectiveness of these interventions to the extent of tries, retinopathy of prematurity and hereditary conditions in current knowledge.